Who is affected by this change?

This affects Independence Blue Cross Hematology, Oncology, Nephrology, Neurology providers on Commercial plans.

When does this change take effect?

This change is effective Jul 9, 2025.

Back to dashboard

CommercialCoverageMedium impact

06.03.04o, Apheresis Therapy

Independence Blue Cross·Hematology, Oncology, Nephrology +1 more·Medical Policy

Effective date

Jul 9, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

The Apheresis Therapy policy (06.03.04o) has been reissued with updates effective July 9, 2025. This is a commercial insurance policy update that may affect billing procedures for apheresis treatments.

Action Required

Action needed

By July 9, 2025: Billing team must review the updated Apheresis Therapy policy at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or billing procedures. Update billing protocols and staff training accordingly for commercial plans offering apheresis therapy services.

Related policy hubs

Independence Blue Cross policies Hematology Oncology Nephrology Neurology